Loading…
Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis
Injury and loss of the endothelial glycocalyx occur during the early phase of sepsis. We previously showed that antithrombin has a protective effect on this structure in vitro. Here, we investigated the possible protective effects of antithrombin in an animal model of sepsis. Wistar rats were inject...
Saved in:
Published in: | Thrombosis research 2018-11, Vol.171, p.1-6 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33 |
---|---|
cites | cdi_FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33 |
container_end_page | 6 |
container_issue | |
container_start_page | 1 |
container_title | Thrombosis research |
container_volume | 171 |
creator | Iba, Toshiaki Levy, Jerrold H. Hirota, Tatsuhiko Hiki, Makoto Sato, Koichi Murakami, Taisuke Nagaoka, Isao |
description | Injury and loss of the endothelial glycocalyx occur during the early phase of sepsis. We previously showed that antithrombin has a protective effect on this structure in vitro. Here, we investigated the possible protective effects of antithrombin in an animal model of sepsis.
Wistar rats were injected with endotoxin, and circulating levels of syndecan-1, hyaluronan, albumin, lactate and other biomarkers were measured in an antithrombin-treated group and an untreated control group (n = 6 in each group). Intravital microscopy was used to observe leukocyte adhesion, microcirculation, and syndecan-1 staining.
The circulating levels of syndecan-1 and hyaluronan were significantly reduced in the antithrombin-treated group, compared with the untreated controls. Lactate levels and albumin reduction were significantly attenuated in the antithrombin-treated group. Intravital microscopic observation revealed that both leukocyte adhesion and blood flow were better maintained in the treatment group. The syndecan-1 lining was disrupted after endotoxin treatment, and this derangement was attenuated by treatment with antithrombin.
Antithrombin effectively maintained microcirculation and vascular integrity by protecting the glycocalyx in a rat sepsis model.
[Display omitted] |
doi_str_mv | 10.1016/j.thromres.2018.09.042 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2105051592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0049384818305267</els_id><sourcerecordid>2105051592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33</originalsourceid><addsrcrecordid>eNqFkMtuFDEQRS1ERCaPX4i8ZNNNlftl70ARAaRIsCBry21XE4-67cHuQZm_x8MkbCOVVJtz66oOYzcINQL2H7b1-pjikijXAlDWoGpoxRu2QTmoSrSDeMs2AK2qGtnKc3aR8xYAB1TdO3begMBeCtww9yPFlezqY-Bx4usjcQoulj17M_Nf88FGa-bDEx8P3ITV_6sdfeBlTDjB8cmHyge3t-R4MitfoqP5eC_TLvt8xc4mM2e6ft6X7OHu88_br9X99y_fbj_dV7btYa2GRpCYlEQhBmddZ4XEqUMnnW1olOPoJhRoTE_CNAYEKJIKre161w_WNc0le3-6u0vx957yqhefLc2zCRT3WQuEDjrslChof0JtijknmvQu-cWkg0bQR8N6q18M66NhDUoXwyV489yxHxdy_2MvSgvw8QRQ-fSPp6Sz9RSKGp-KaO2if63jL0xjkpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2105051592</pqid></control><display><type>article</type><title>Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Iba, Toshiaki ; Levy, Jerrold H. ; Hirota, Tatsuhiko ; Hiki, Makoto ; Sato, Koichi ; Murakami, Taisuke ; Nagaoka, Isao</creator><creatorcontrib>Iba, Toshiaki ; Levy, Jerrold H. ; Hirota, Tatsuhiko ; Hiki, Makoto ; Sato, Koichi ; Murakami, Taisuke ; Nagaoka, Isao</creatorcontrib><description>Injury and loss of the endothelial glycocalyx occur during the early phase of sepsis. We previously showed that antithrombin has a protective effect on this structure in vitro. Here, we investigated the possible protective effects of antithrombin in an animal model of sepsis.
Wistar rats were injected with endotoxin, and circulating levels of syndecan-1, hyaluronan, albumin, lactate and other biomarkers were measured in an antithrombin-treated group and an untreated control group (n = 6 in each group). Intravital microscopy was used to observe leukocyte adhesion, microcirculation, and syndecan-1 staining.
The circulating levels of syndecan-1 and hyaluronan were significantly reduced in the antithrombin-treated group, compared with the untreated controls. Lactate levels and albumin reduction were significantly attenuated in the antithrombin-treated group. Intravital microscopic observation revealed that both leukocyte adhesion and blood flow were better maintained in the treatment group. The syndecan-1 lining was disrupted after endotoxin treatment, and this derangement was attenuated by treatment with antithrombin.
Antithrombin effectively maintained microcirculation and vascular integrity by protecting the glycocalyx in a rat sepsis model.
[Display omitted]</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/j.thromres.2018.09.042</identifier><identifier>PMID: 30216821</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Animals ; Antithrombin ; Antithrombin Proteins - therapeutic use ; Antithrombins - therapeutic use ; Endothelium ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - immunology ; Endothelium, Vascular - pathology ; Endotoxins - immunology ; Glycocalyx - drug effects ; Glycocalyx - immunology ; Glycocalyx - pathology ; Hyaluronan ; Hyaluronic Acid - blood ; Hyaluronic Acid - immunology ; Inflammation ; Inflammation - blood ; Inflammation - drug therapy ; Inflammation - immunology ; Inflammation - pathology ; Microcirculation ; Microcirculation - drug effects ; Rats, Wistar ; Sepsis ; Sepsis - blood ; Sepsis - drug therapy ; Sepsis - immunology ; Sepsis - pathology ; Syndecan-1 ; Syndecan-1 - blood ; Syndecan-1 - immunology</subject><ispartof>Thrombosis research, 2018-11, Vol.171, p.1-6</ispartof><rights>2018 Elsevier Ltd</rights><rights>Copyright © 2018 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33</citedby><cites>FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33</cites><orcidid>0000-0002-0255-4088</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30216821$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iba, Toshiaki</creatorcontrib><creatorcontrib>Levy, Jerrold H.</creatorcontrib><creatorcontrib>Hirota, Tatsuhiko</creatorcontrib><creatorcontrib>Hiki, Makoto</creatorcontrib><creatorcontrib>Sato, Koichi</creatorcontrib><creatorcontrib>Murakami, Taisuke</creatorcontrib><creatorcontrib>Nagaoka, Isao</creatorcontrib><title>Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>Injury and loss of the endothelial glycocalyx occur during the early phase of sepsis. We previously showed that antithrombin has a protective effect on this structure in vitro. Here, we investigated the possible protective effects of antithrombin in an animal model of sepsis.
Wistar rats were injected with endotoxin, and circulating levels of syndecan-1, hyaluronan, albumin, lactate and other biomarkers were measured in an antithrombin-treated group and an untreated control group (n = 6 in each group). Intravital microscopy was used to observe leukocyte adhesion, microcirculation, and syndecan-1 staining.
The circulating levels of syndecan-1 and hyaluronan were significantly reduced in the antithrombin-treated group, compared with the untreated controls. Lactate levels and albumin reduction were significantly attenuated in the antithrombin-treated group. Intravital microscopic observation revealed that both leukocyte adhesion and blood flow were better maintained in the treatment group. The syndecan-1 lining was disrupted after endotoxin treatment, and this derangement was attenuated by treatment with antithrombin.
Antithrombin effectively maintained microcirculation and vascular integrity by protecting the glycocalyx in a rat sepsis model.
[Display omitted]</description><subject>Animals</subject><subject>Antithrombin</subject><subject>Antithrombin Proteins - therapeutic use</subject><subject>Antithrombins - therapeutic use</subject><subject>Endothelium</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - immunology</subject><subject>Endothelium, Vascular - pathology</subject><subject>Endotoxins - immunology</subject><subject>Glycocalyx - drug effects</subject><subject>Glycocalyx - immunology</subject><subject>Glycocalyx - pathology</subject><subject>Hyaluronan</subject><subject>Hyaluronic Acid - blood</subject><subject>Hyaluronic Acid - immunology</subject><subject>Inflammation</subject><subject>Inflammation - blood</subject><subject>Inflammation - drug therapy</subject><subject>Inflammation - immunology</subject><subject>Inflammation - pathology</subject><subject>Microcirculation</subject><subject>Microcirculation - drug effects</subject><subject>Rats, Wistar</subject><subject>Sepsis</subject><subject>Sepsis - blood</subject><subject>Sepsis - drug therapy</subject><subject>Sepsis - immunology</subject><subject>Sepsis - pathology</subject><subject>Syndecan-1</subject><subject>Syndecan-1 - blood</subject><subject>Syndecan-1 - immunology</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFkMtuFDEQRS1ERCaPX4i8ZNNNlftl70ARAaRIsCBry21XE4-67cHuQZm_x8MkbCOVVJtz66oOYzcINQL2H7b1-pjikijXAlDWoGpoxRu2QTmoSrSDeMs2AK2qGtnKc3aR8xYAB1TdO3begMBeCtww9yPFlezqY-Bx4usjcQoulj17M_Nf88FGa-bDEx8P3ITV_6sdfeBlTDjB8cmHyge3t-R4MitfoqP5eC_TLvt8xc4mM2e6ft6X7OHu88_br9X99y_fbj_dV7btYa2GRpCYlEQhBmddZ4XEqUMnnW1olOPoJhRoTE_CNAYEKJIKre161w_WNc0le3-6u0vx957yqhefLc2zCRT3WQuEDjrslChof0JtijknmvQu-cWkg0bQR8N6q18M66NhDUoXwyV489yxHxdy_2MvSgvw8QRQ-fSPp6Sz9RSKGp-KaO2if63jL0xjkpA</recordid><startdate>20181101</startdate><enddate>20181101</enddate><creator>Iba, Toshiaki</creator><creator>Levy, Jerrold H.</creator><creator>Hirota, Tatsuhiko</creator><creator>Hiki, Makoto</creator><creator>Sato, Koichi</creator><creator>Murakami, Taisuke</creator><creator>Nagaoka, Isao</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0255-4088</orcidid></search><sort><creationdate>20181101</creationdate><title>Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis</title><author>Iba, Toshiaki ; Levy, Jerrold H. ; Hirota, Tatsuhiko ; Hiki, Makoto ; Sato, Koichi ; Murakami, Taisuke ; Nagaoka, Isao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Antithrombin</topic><topic>Antithrombin Proteins - therapeutic use</topic><topic>Antithrombins - therapeutic use</topic><topic>Endothelium</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - immunology</topic><topic>Endothelium, Vascular - pathology</topic><topic>Endotoxins - immunology</topic><topic>Glycocalyx - drug effects</topic><topic>Glycocalyx - immunology</topic><topic>Glycocalyx - pathology</topic><topic>Hyaluronan</topic><topic>Hyaluronic Acid - blood</topic><topic>Hyaluronic Acid - immunology</topic><topic>Inflammation</topic><topic>Inflammation - blood</topic><topic>Inflammation - drug therapy</topic><topic>Inflammation - immunology</topic><topic>Inflammation - pathology</topic><topic>Microcirculation</topic><topic>Microcirculation - drug effects</topic><topic>Rats, Wistar</topic><topic>Sepsis</topic><topic>Sepsis - blood</topic><topic>Sepsis - drug therapy</topic><topic>Sepsis - immunology</topic><topic>Sepsis - pathology</topic><topic>Syndecan-1</topic><topic>Syndecan-1 - blood</topic><topic>Syndecan-1 - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iba, Toshiaki</creatorcontrib><creatorcontrib>Levy, Jerrold H.</creatorcontrib><creatorcontrib>Hirota, Tatsuhiko</creatorcontrib><creatorcontrib>Hiki, Makoto</creatorcontrib><creatorcontrib>Sato, Koichi</creatorcontrib><creatorcontrib>Murakami, Taisuke</creatorcontrib><creatorcontrib>Nagaoka, Isao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iba, Toshiaki</au><au>Levy, Jerrold H.</au><au>Hirota, Tatsuhiko</au><au>Hiki, Makoto</au><au>Sato, Koichi</au><au>Murakami, Taisuke</au><au>Nagaoka, Isao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2018-11-01</date><risdate>2018</risdate><volume>171</volume><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>Injury and loss of the endothelial glycocalyx occur during the early phase of sepsis. We previously showed that antithrombin has a protective effect on this structure in vitro. Here, we investigated the possible protective effects of antithrombin in an animal model of sepsis.
Wistar rats were injected with endotoxin, and circulating levels of syndecan-1, hyaluronan, albumin, lactate and other biomarkers were measured in an antithrombin-treated group and an untreated control group (n = 6 in each group). Intravital microscopy was used to observe leukocyte adhesion, microcirculation, and syndecan-1 staining.
The circulating levels of syndecan-1 and hyaluronan were significantly reduced in the antithrombin-treated group, compared with the untreated controls. Lactate levels and albumin reduction were significantly attenuated in the antithrombin-treated group. Intravital microscopic observation revealed that both leukocyte adhesion and blood flow were better maintained in the treatment group. The syndecan-1 lining was disrupted after endotoxin treatment, and this derangement was attenuated by treatment with antithrombin.
Antithrombin effectively maintained microcirculation and vascular integrity by protecting the glycocalyx in a rat sepsis model.
[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>30216821</pmid><doi>10.1016/j.thromres.2018.09.042</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-0255-4088</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0049-3848 |
ispartof | Thrombosis research, 2018-11, Vol.171, p.1-6 |
issn | 0049-3848 1879-2472 |
language | eng |
recordid | cdi_proquest_miscellaneous_2105051592 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Animals Antithrombin Antithrombin Proteins - therapeutic use Antithrombins - therapeutic use Endothelium Endothelium, Vascular - drug effects Endothelium, Vascular - immunology Endothelium, Vascular - pathology Endotoxins - immunology Glycocalyx - drug effects Glycocalyx - immunology Glycocalyx - pathology Hyaluronan Hyaluronic Acid - blood Hyaluronic Acid - immunology Inflammation Inflammation - blood Inflammation - drug therapy Inflammation - immunology Inflammation - pathology Microcirculation Microcirculation - drug effects Rats, Wistar Sepsis Sepsis - blood Sepsis - drug therapy Sepsis - immunology Sepsis - pathology Syndecan-1 Syndecan-1 - blood Syndecan-1 - immunology |
title | Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A16%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protection%20of%20the%20endothelial%20glycocalyx%20by%20antithrombin%20in%20an%20endotoxin-induced%20rat%20model%20of%20sepsis&rft.jtitle=Thrombosis%20research&rft.au=Iba,%20Toshiaki&rft.date=2018-11-01&rft.volume=171&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/j.thromres.2018.09.042&rft_dat=%3Cproquest_cross%3E2105051592%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2105051592&rft_id=info:pmid/30216821&rfr_iscdi=true |